News

The agreement follows negotiations with Moderna, who recently reported that interim data for its vaccine-candidate shows it is nearly 95% effective. The 5 millions doses would be enough for up to 2.5 million people in the UK, given that...

Moderna Inc. on Monday declared that its vaccine was 94.5% effective. This came just after a week when Pfizer & its partner BioNTech SE had gone public to state that their vaccine is more than 90% effective. There is...

Virgin Atlantic Cargo has added a new pharma service ahead of the launch of a new Covid-19 vaccine. The airline said its new Pharma Secure service will cater for urgent, valuable and vulnerable pharmaceutical and life sciences shipments. The product...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced a supply agreement with the government of the United Kingdom to supply mRNA-1273, its COVID-19 vaccine...

Moderna, Inc.,a biotechnology company pioneering messenger RNA therapeutics and vaccines to create a new generation of transformative medicines for patients, announced that the EMA human medicines committee (CHMP) has started a rolling review of mRNA-1273, the Company’s vaccine candidate...

The public will be better protected from COVID-19 with £12.2 million of funding awarded to potentially life-saving research into how the virus spreads and evolves through genome sequencing. The COVID-19 Genomics UK (COG-UK) Consortium will use the funding to expand...

Abzena, a global partner research organization for integrated bench to market solutions for biologics and bioconjugates, has announced upgrades of its chemistry GMP suites. The Bristol PA site manufacturing facility upgrades allow Abzena’s ADC client projects to seamlessly progress from...